الصفحة الرئيسية>>Signaling Pathways>> PROTAC>> PROTAC and Building Blocks>>PROTAC EED degrader-2

PROTAC EED degrader-2

رقم الكتالوجGC62717

PROTAC EED degrader-2 هو PROTAC مقره فون هيبل لينداو يستهدف EED مع pKD 9.27PROTAC EED degrader-2 هو مثبط مركب قمعي 2 (PRC2) متعدد القواطع (pIC50 = 8.11) يستهدف الوحدة الفرعية EED

Products are for research use only. Not for human use. We do not sell to patients.

PROTAC EED degrader-2 التركيب الكيميائي

Cas No.: 2639882-69-0

الحجم السعر المخزون الكميّة
5 mg
855٫00
متوفر
10 mg
1485٫00
متوفر
25 mg
3105٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

PROTAC EED degrader-2 is a PROTAC targeting EED with a pKD of 9.27. PROTAC EED degrader-2 is a polycomb repressive complex 2 (PRC2) inhibitor (pIC50=8.11) targeting the EED subunit[1].

PROTAC EED degrader-2 (Compound PROTAC 1) binds to EED with a pKD of 9.27±0.05 and inhibits PRC2 function with a pIC50 of 8.11±0.09[1]. PROTAC EED degrader-2 (0.01-100 μM; 14 days) can potently inhibit proliferation of an EZH2 mutant DLBCL cell line Karpas422[1]. PROTAC EED degrader-2 (0.1-3 μM; 48 hours) reduces the protein levels of EED, EZH2, H3K27me3 in Karpas422 cells[1].PROTAC EED degrader-2 (1 μM ; 1-24 h) promotes degradation of EED, EZH2, and SUZ12 in Karpas422 cells[1].

[1]. Hsu JH, et al. EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex. Cell Chem Biol. 2019 Nov 26. pii: S2451-9456(19)30362-9.

مراجعات

Review for PROTAC EED degrader-2

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PROTAC EED degrader-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.